3-D doppler ultrasound helps identify breast cancer

Key points
- Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology.
- "Using 3-D scans promises greater accuracy due to more consistent sampling over the entire tumor," said lead author, Gerald L.
- Malignant breast masses often exhibit increased blood flow compared to normal tissue or benign masses.
- LeCarpentier and colleagues studied 78 women between the ages of 26 and 70 who where scheduled for biopsy of a suspicious breast mass.
Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology.
"Using 3-D scans promises greater accuracy due to more consistent sampling over the entire tumor," said lead author, Gerald L. LeCarpentier, Ph.D., assistant professor in the Department of Radiology at University of Michigan in Ann Arbor. "Our study shows that 3-D power Doppler ultrasound may be useful in the evaluation of some breast masses."
Malignant breast masses often exhibit increased blood flow compared to normal tissue or benign masses. Using 3-D power Doppler ultrasound, radiologists are able to detect vessels with higher flow speeds, which likely indicate cancer.
For the study, Dr. LeCarpentier and colleagues studied 78 women between the ages of 26 and 70 who where scheduled for biopsy of a suspicious breast mass. Each of the women underwent a 3-D Doppler ultrasound exam followed by core or excisional biopsy of the breast.
The results showed that 3-D power Doppler ultrasound was highly accurate in identifying malignant breast tumors. When combined with age-based assessment and gray scale visual analysis, 3-D Doppler showed a sensitivity of 100 percent in identifying cancerous tumors and a specificity of 86 percent in excluding benign tumors.
"Using speed-weighted 3-D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded," Dr. LeCarpentier said.
###
"Suspicious Breast Lesions: Assessment of 3D Doppler US Indexes for Classification in a Test Population and Fourfold Cross-Validation Scheme." Collaborating with Dr. LeCarpentier were Marilyn A. Roubidoux, M.D., J. Brian Fowlkes, Ph.D., Jochen F. Krücker, Ph.D., Karen A. Hunt, M.D., Chintana Paramagul, M.D., Timothy D. Johnson, Ph.D., Nancy J. Thorson, R.T., R.D.M.S., C.C.R.P., M.F.A., Karen D. Engle, M.L.S., and Paul L. Carson, Ph.D. Journal attribution requested.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc.
The Radiological Society of North America (RSNA) is an association of more than 41,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research.
Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsIdentify Depressive Symptoms Early in Breast Cancer Patients
More than one in four women who were later diagnosed with breast cancer had a combined state anxiety and depressive symptoms, and this helped predict quality of life, state anxiety, depressive symptoms, and fatigue at…
21 March 2012
NewsResearchers identify possible receptor for key breast cancer regulator
A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the…
14 January 2012
NewsStudy helps eliminate causes for joint pain linked to commonly used breast cancer drugs
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: inflammatory arthritis and autoimmune disease. Because of these findings,…



